Ursodiol USP/EP For Compounding (API)

Ursodiol USP/EP for Compounding (API) is an active pharmaceutical ingredient used to create customized medications for liver and gallbladder conditions. It is primarily used to dissolve gallstones and to treat primary biliary cholangitis by reducing cholesterol absorption and improving bile flow. Ursodiol helps manage certain liver diseases by protecting liver cells from damage. Through compounding, pharmacists can tailor dosages and formulations to individual patient needs, ensuring optimized treatment outcomes and better management of hepatobiliary disorders.

Ursodiol USP is a pharmaceutical agent used in the treatment of liver and gallbladder disorders. It is an active pharmaceutical ingredient (API) that is the main component responsible for the therapeutic effects of medicines containing ursodiol. It is extracted from the bile of bears and undergoes a process of purification to produce a synthetic version that is used in medication. Ursodiol USP is a bile acid that helps to dissolve cholesterol and bile salts in the gallbladder, preventing the formation of gallstones and improving liver function. In addition, it has anti-inflammatory and immunomodulatory properties that have been found useful in the treatment of certain liver diseases. 

Ursodiol USP for compounding is a medication used for the treatment of conditions related to gallstone formation, such as primary biliary cholangitis and gallstone dissolution. It is used in compounding pharmacies to prepare customized formulations for patients with specific needs. Ursodiol works by decreasing the production of cholesterol in the liver and promoting the dissolution of cholesterol-based gallstones. It also has anti-inflammatory properties and can help protect the liver from damage.

CAS Number: 128-13-2